[Oxytocin (OT) and 13,14-dihydro-15-keto-PGF2 alpha (PGFM) levels after intracervical administration of PGE2 gel combined with administration of beta mimetics; biochemical changes and clinical consequences]. (Record no. 6557807)

MARC details
000 -LEADER
fixed length control field 01478 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512221655.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198402s 0 0 ger d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0016-5751
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-2008-1036717
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Goeschen, K
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19840222
245 00 - TITLE STATEMENT
Title [Oxytocin (OT) and 13,14-dihydro-15-keto-PGF2 alpha (PGFM) levels after intracervical administration of PGE2 gel combined with administration of beta mimetics; biochemical changes and clinical consequences].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Geburtshilfe und Frauenheilkunde
Date of publication, distribution, etc. Oct 1983
300 ## - PHYSICAL DESCRIPTION
Extent 589-93 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Topical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cervix Uteri
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ethanolamines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fenoterol
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Myometrium
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxytocin
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Placebos
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pregnancy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostaglandins E
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostaglandins F
General subdivision blood
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fuchs, A R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rasmussen, A B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fuchs, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Saling, E
773 0# - HOST ITEM ENTRY
Title Geburtshilfe und Frauenheilkunde
Related parts vol. 43
-- no. 10
-- p. 589-93
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-2008-1036717">https://doi.org/10.1055/s-2008-1036717</a>
Public note Available from publisher's website

No items available.